Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Manoranjani P.M. Tillekeratne"'
Publikováno v:
Cancer research. 79(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2027487648702d7367d43be08092e02d
https://pubmed.ncbi.nlm.nih.gov/15059906
https://pubmed.ncbi.nlm.nih.gov/15059906
Autor:
Runming Jin, Manoranjani P.M. Tillekeratne, Qiqi Ye, Lijun Liu, Jiang Tian, Zijian Xie, Xin Li, Peter Kometiani, Joe X. Xie, Man Liang
Publikováno v:
Journal of Biological Chemistry. 284:14921-14929
Here we show that ouabain-induced cell growth regulation is intrinsically coupled to changes in the cellular amount of Na/K-ATPase via the phosphoinositide 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway. Ouabain increases the endocy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb287b309a65be070f420d7231d30d14
https://doi.org/10.1074/jbc.m808355200
https://doi.org/10.1074/jbc.m808355200
Autor:
Sumudra Periyasamy, Weinian Shou, Manoranjani P.M. Tillekeratne, Edwin R. Sanchez, Manya Warrier
Publikováno v:
Endocrinology. 148:4716-4726
The androgen receptor (AR) contributes to growth of prostate cancer even under conditions of androgen ablation. Thus, new strategies to target AR activity are needed. The AR interacts with the immunophilin FK506-binding protein 52 (FKBP52), and studi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec601ec66526648f860c881abe35aa21
https://doi.org/10.1210/en.2007-0145
https://doi.org/10.1210/en.2007-0145
Publikováno v:
Cancer research. 64(7)
Tumor progression due to loss of autocrine negative transforming growth factor-β (TGF-β) activity was reported in various cancers of epithelial origin. Estrogen receptor expressing (ER+) breast cancer cells are refractory to TGF-β effects and exhi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b504f0320d8e40d6d90e62b63d32696
https://pubmed.ncbi.nlm.nih.gov/34465568
https://pubmed.ncbi.nlm.nih.gov/34465568
Autor:
Michael G. Brattain, Sumudra Periyasamy, Sudhakar Ammanamanchi, Manoranjani P.M. Tillekeratne
Publikováno v:
Oncogene. 19(40)
In this report, we describe the mechanism of TGF-beta receptor type I (RI) repression in the GEO human colon carcinoma cells. Treatment of GEO cells with the DNA methyltransferase inhibitor, 5 azacytidine induced RI expression and restored TGF-beta r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7945dd190d5a8895be0698f3de45fed5
https://pubmed.ncbi.nlm.nih.gov/11030155
https://pubmed.ncbi.nlm.nih.gov/11030155